The stock is down 32% since Barron’s highlighted it but there are reasons to expect better returns going forward.
Follow-Up
Technical indicators point to near-term upside for the three stocks.
Chevron is up 40% since we picked it. There’s more upside ahead.
The stock has more than doubled since we recommended buying it. More upside awaits.
The stock sold off after earnings but there are reasons to stay invested.
The stock is still packed with positive catalysts.
Amgen has performed decently but it’s best returns are still ahead.
The stock hasn't performed well since Barron’s picked it.
Many worst-case scenarios are already priced in, especially compared with competitors.
Investors are punishing the stock. This short-term reaction creates a buying opportunity.
The stock is roughly flat since our pick. We have reason to believe it will rally.
Shares are down 12% since our recommendation. Time to cut losses.
The equipment manufacturer’s stock has outperformed the S&P 500 since we recommended buying it a year ago. Let it ride.
Earnings beat expectations but the stock still dropped. The thesis remains intact. Stay invested.
Innodata stock has gained 73% since our recommendation. This deal only helps.
The deal for Penumbra will pay off in the long run. Hang on to the shares.
The company has found its calling curating data used to train AI models. Stay invested.
Chevron, Boeing, and Colgate-Palmolive feature in this week’s column.
The stock is pricing in headwinds while discounting the success of its AV business.
Shares are down significantly, but the valuation and growth story remain compelling.
A consumer discretionary name, a media company, and an industrial.
Shares look a lot cheaper following a recent selloff, and they are well-positioned to rally however the takeover battle shakes out.
Our thesis, that Twilio can take a sizable chunk of its $100 billion market remains intact.
Twelve months after our pick, the clothing retailer looks to have turned the corner.
The company’s shares have gained 70% since Barron’s recommended them in December. They’re worth holding despite the jump.